Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eye prosthesis socket discomfort and discharge treatment comparison
NL-OMON58622Phase 4Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2024
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sodium hyaluronate and vitamin a in anophthalmic socket syndrome (ASS) and Chronic mucopurulent discharge of the ocular prosthesis socket (3 arms), sponsored by Amsterdam University Medical Center. Started Feb 2024; status: completed.
02
Drugs
sodium hyaluronatevitamin a
03
Conditions
anophthalmic socket syndrome (ASS)Chronic mucopurulent discharge of the ocular prosthesis socket
Beyond the preview
Go deeper on NL-OMON58622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58622.